![C50H58N7O9P Adenosin, N-benzoyl-5' -O- [bis(4-methoxyphenyl)phenylmethyl]-2' - O-(2-methoxyethyl)-, 3' - [2-cyanoethyl N,N-bis(1-methylethyl) ) phosphoramidit] (ACI)](http://cdn.globalso.com/nvchem/style/global/img/demo/page_banner.jpg)
![C50H58N7O9P Adenosin, N-benzoyl-5' -O- [bis(4-methoxyphenyl)phenylmethyl]-2' - O-(2-methoxyethyl)-, 3' - [2-cyanoethyl N,N-bis(1-methylethyl) ) phosphoramidite] (ACI) Ausgezeechent Bild](https://www.csnvchem.com/uploads/C50H58N7O9P-Adenosine.png)
C50H58N7O9P Adenosin, N-benzoyl-5' -O- [bis(4-methoxyphenyl)phenylmethyl]-2' - O-(2-methoxyethyl)-, 3' - [2-cyanoethyl N,N-bis(1-methylethyl) ) phosphoramidit] (ACI)
CAS Registréierungsnummer
251647-53-7
H302
| Schlëssel kierperlech Eegeschaften | Wäert | Zoustand |
| Molekulare Gewiicht | 932.01 | - |
| pKa (virausgesot) | 7,87±0,43 | Déi meescht sauer Temperatur: 25 °C |
Kanonesch SMILES
N#CCCOP(OC1C(OC(N2C= NC=3C(= NC= NC32)NC(=O)C=4C=CC=CC4)C1OCCOC)COC(C=5C=CC=CC5)(C6=CC=C (OC)C=C6)C7=CC=C(OC) C=C7)N(C(C)C)C(C)C
Isomeric SMILES
C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](OCCOC)[C@@ H](O1)N2C=3C(N=C2)=C(NC(=O)C4=CC=CC=C4)N=CN3)(C5 =CC=C(OC)C=C5)(C6=CC =C(OC)C=C6)C7=CC=CC=C7
InChI
InChI= 1S/C50H58N7O9P/c1-34(2)57(35(3)4)67(64-28-14-27-51)66-44-42(31-63-50(37-17-12- 9-13-18-37,38-19-23-40(60-6)24-20-38)3 9-21-25-41(61-7)26-22-39)65-49(45) (44)62-30-29-59-5)56-33-54-43-46(52-32-53-47(43)56)55-48(58)36-15-10-8-11 -16-36/h8-13,15-26, 32-35,42,44-45,49H,14,28-31H2,1-7H3,(H,52,53,55,58)/t42-, 44-,45-,49-,67?/m1/s1
InChI Schlëssel
VPBYBQBHLYRLHG-HDMAWCRFSA-N
16 Aner Nimm fir dës Substanz
Adenosin,N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-, 3'- [2-cyanoethyl bis(1-methylethyl)
phosphoramidit] (9CI); 16: PN: US20030211606 SÄIT: 19 behaapt Rei; 16: PN: US20030212017 SÄIT: 20 behaapt Rei; 17: PN: US20040005569 SÄIT: 22 behaapt Rei; 19: PN: US20040006030 SÄIT: 23 behaapt Rei; 19: PN: US20040014047
PAGE: 21 behaapt Sequenz; 19: PN: US20040014049 SÄIT: 21 behaapt Rei; 20: PN: US20040005570 PAGE: 20 behaapt
Sequenz; 20: PN: US20040014048 SÄIT: 21 behaapt Sequenz; 20: PN: US20040014050 SÄIT: 20 behaapt Rei; 21: PN: U
S20040005565 PAGE: 17- 22 behaapt Sequenz; 21: PN: US20040014051 SÄIT: 23 behaapt Rei; 22: PN: US20040014699 SÄIT: 20 behaapt Rei; 23: PN: US20040006029 SÄIT: 23 behaapt Rei; 23: PN: WO03106645 SÄIT: 73 behaapt Rei; 94: P N: US20040005707 PAGE: 20 behaapt Sequenz
Spektrum verfügbar
1H NMR
13 C NMR
Hetero NMR
Eegeschafte verfügbar
Biologesch
Chemesch
Lipinski
Struktur Zesummenhang
| Immobilie | Wäert | Zoustand | Quell |
| Biokonzentratiounsfaktor | 2680 | pH 1; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 71500 | pH 2; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 7,21 x 105 | pH 3; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 4; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 5; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 6; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,00 x 106 | pH 7; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 8,48 x 105 | pH 8; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,39 x 105 | pH 9; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 40 300 | pH 10; Temperatur: 25 °C | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Zoustand | Quell |
| Koc | 1360 | pH 1; Temperatur: 25 °C | (1) ACD |
| Koc | 36 300 | pH 2; Temperatur: 25 °C | (1) ACD |
| Koc | 3,66 x 105 | pH 3; Temperatur: 25 °C | (1) ACD |
| Koc | 1,13 x 106 | pH 4; Temperatur: 25 °C | (1) ACD |
| Immobilie | Wäert | Zoustand | Quell |
| Koc | 1,42 x 106 | pH 5; Temperatur: 25 °C | (1) ACD |
| Koc | 1,42 x 106 | pH 6; Temperatur: 25 °C | (1) ACD |
| Koc | 1,17 x 106 | pH 7; Temperatur: 25 °C | (1) ACD |
| Koc | 4,30 x 105 | pH 8; Temperatur: 25 °C | (1) ACD |
| Koc | 7 0800 | pH 9; Temperatur: 25 °C | (1) ACD |
| Koc | 20500 | pH 10; Temperatur: 25 °C | (1) ACD |
| log D | 5,77 | pH 1; Temperatur: 25 °C | (1) ACD |
| log D | 7.20 | pH 2; Temperatur: 25 °C | (1) ACD |
| log D | 8.20 | pH 3; Temperatur: 25 °C | (1) ACD |
| log D | 8,69 | pH 4; Temperatur: 25 °C | (1) ACD |
| log D | 8,79 | pH 5; Temperatur: 25 °C | (1) ACD |
| log D | 8,79 | pH 6; Temperatur: 25 °C | (1) ACD |
| log D | 8,71 | pH 7; Temperatur: 25 °C | (1) ACD |
| log D | 8.27 | pH 8; Temperatur: 25 °C | (1) ACD |
| log D | 7.49 | pH 9; Temperatur: 25 °C | (1) ACD |
| log D | 6,95 | pH 10; Temperatur: 25 °C | (1) ACD |
| logP | 8,803±0,766 | Temperatur: 25 °C | (1) ACD |
| Mass Intrinsesch Solubilitéit | 5,4 x 10-5 g/l | Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 0,051 g/l | pH 1; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,9 x 10-3 g/l | pH 2; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,9 x 10-4 g/l | pH 3; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 6,0 x 10-5 g/l | pH 4; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 4,8 x 10-5 g/l | pH 5; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 4,8 x 10-5 g/l | pH 6; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 5,8 x 10-5 g/l | pH 7; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,6 x 10-4 g/L | pH 8; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 9,3 x 10-4 g/L | pH 9; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 3,6 x 10-3 g/l | pH 10; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 5,7 x 10-5 g/l | Ongebuffert Waasser pH 6,97; Temperatur: 25 °C | (1) ACD |
| Molar Intrinsesch Solubilitéit | 5,8 x 10-8 mol/l | Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 5,5 x 10-5 mol/l | pH 1; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 2,0 x 10-6 mol/l | pH 2; Temperatur: 25 °C | (1) ACD |
| Immobilie | Wäert | Zoustand | Quell |
| Molar Solubilitéit | 2,0 x 10-7 mol/l | pH 3; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 6,4 x 10-8 mol/l | pH 4; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 5,1 x 10-8 mol/l | pH 5; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 5,1 x 10-8 mol/l | pH 6; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 6,2 x 10-8 mol/l | pH 7; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,7 x 10-7 mol/l | pH 8; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,0 x 10-6 mol/l | pH 9; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 3,9 x 10-6 mol/l | pH 10; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 6,1 x 10-8 mol/l | Ongebuffert Waasser pH 6,97; Temperatur: 25 °C | (1) ACD |
| Molekulare Gewiicht | 932.01 | ||
| pKa | 7,87±0,43 | Déi meescht sauer Temperatur: 25 °C | (1) ACD |
| pKa | 3,45±0,70 | Déi meescht Basistemperatur: 25 °C | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Zoustand | Quell |
| Fräi rotéierbar Obligatiounen | 22 | (1) ACD | |
| H Akzepter | 16 | (1) ACD | |
| H Donateuren | 1 | (1) ACD | |
| H Donateur / Akzeptanz Zomm | 17 | (1) ACD | |
| logP | 8,803±0,766 | Temperatur: 25 °C | (1) ACD |
| Molekulare Gewiicht | 932.01 |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Conditioun Quell |
| Polar Fläch Beräich | 187 A2 | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
Spektrum verfügbar
1H NMR
13 C NMR
| Code Hazard Statement Quell | |
| H302 schiedlech beim Schlucken | Europäesch Chemesch Agentur (ECHA) Klassifikatioun a Label Inventaire - Notifizéiert Klassifikatioun an Etikettéierung - meescht üblech Notifikatiounen, European Chemical Agency (ECHA) Klassifikatioun & Etikettéieren Inventar - Notifizéiert Klassifikatioun an Etikettéieren - déi seriöst Notifikatiounen |
![C44H53FN7O8 Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl N, N-bis(1-Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C44H53FN7O8-300x300.png)
![C42H52N5O9P Cytidin, N-acetyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] ( ACI)](https://www.csnvchem.com/uploads/C42H52N5O9P-Cytidine-300x300.png)
![C43H55N4O10P Uridin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)- 5-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-) Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C43H55N4O10P-Uridine-300x300.png)
![C40H49N4O9P Uridin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C40H49N4O9P-Uridine-300x300.png)
![C50H60N5O10P Cytidin, N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O- (2-methoxyethyl)- 5-methyl-, 3'- [2-cyanoethyl-N,N-bis (1-Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C50H60N5O10P-Cytidine-300x300.png)
![C47H51FN7O7P Adenosin, N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'- deoxy-2'-fluoro-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl) Phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C47H51FN7O7P-Adenosine-300x300.png)